Contralateral Cancer Professors and Supervisors

Cindy B. Matsenمشاهده پروفایل

دانشیار

University of UtahUnited States

Cindy B. Matsen is a fellowship-trained Associate Professor in the Department of Surgery at the University of Utah , affiliated with the Huntsman Cancer Institute . Board-certified in General Surgery, she specializes in breast cancer surgery and benign breast diseases. Undergraduate: University of Oregon (Biology) MD: University of Chicago Pritzker School of Medicine Residency: General Surgery at University of Utah Fellowship: Breast Surgical Oncology at Memorial Sloan Kettering Cancer Center Her research focuses on shared decision making , health communication , and cancer care delivery , with a particular emphasis on preference elicitation for improved cancer outcomes. She collaborates across communication , population health , epidemiology , engineering , and molecular biology fields. Recent publications highlight her work on: Breast cancer staging and surgical outcomes Clinical trial design (NRG-BR005, I-SPY2) Cancer survivorship during the COVID-19 pandemic Medical imaging techniques for invasive lobular carcinomas Telehealth implementation in oncology care Clinically, she operates at: Huntsman Cancer Institute - Cancer Hospital North 2K (Salt Lake City) Sugar House Health Center (Salt Lake City) Patient reviews consistently highlight her professionalism , compassion , and clear communication regarding diagnoses and treatment options.

پروفایل رسمی دانشگاه

Jonine Lisa Bernsteinمشاهده پروفایل

پژوهشگر

Memorial Sloan Kettering Cancer CenterUnited States

Jonine Lisa Bernstein is a Researcher at the Department of Epidemiology & Biostatistics at Memorial Sloan Kettering Cancer Center (MSK). She serves as Co-Leader of the Population Sciences Research Program and leads the WECARE Study (Women’s Environmental, Cancer, and Radiation Epidemiology), focusing on genetic susceptibility, radiation therapy effects, and environmental factors in contralateral breast cancer. Her research spans genetic and molecular epidemiology of breast cancer and gliomas, with emphasis on broad fields including Genetic Epidemiology , Cancer Risk Prediction , and Radiation-Associated Cancers . Key Research Areas: Genetic susceptibility to contralateral breast cancer Development/validation of imaging biomarkers (e.g., mammographic density, MRI background parenchymal enhancement) Gene-environment interactions in cancer progression Non-cancer outcomes post-breast cancer treatment Molecular pathoepidemiology of gliomas Her recent publications analyze radiation-induced breast cancer risks, DNA repair gene variants, and AI-driven GWAS. She collaborates with institutions like Stanford and MD Anderson on glioma studies and serves on advisory boards for the U.S. EPA and Radiation Effects Research Foundation. Scientific awards include leadership roles in the American College of Epidemiology and American Epidemiological Society.

پروفایل رسمی دانشگاه

Guro Kristine Kleivi Sahlbergمشاهده پروفایل

استاد

University of OsloNorway

Guro Kristine Kleivi Sahlberg is a Professor at the Institute for Cancer Research, University of Oslo. Her work spans breast cancer genetics, molecular oncology, and tumor biology, with a focus on microRNA regulation, polygenic risk scores, and genetic variant impacts. Primary Affiliation: Institute for Cancer Research, University of Oslo Academic Rank: Professor Email: g.k.k.sahlberg@medisin.uio.no Research Themes: Dr. Sahlberg investigates how genetic variations influence breast cancer susceptibility and outcomes. Her recent studies include polygenic risk score implementation, tumor immune microenvironment characterization, and therapeutic target identification through high-throughput screening. Scientific Collaboration: She contributes to large-scale consortiums analyzing germline variants, tumor subtypes, and treatment responses across diverse populations, emphasizing precision medicine applications. Notable Article Trends: Her publications highlight microRNA-HER2 interactions, FANCM variants in DNA repair, and immune profiling of metastatic breast cancer, demonstrating interdisciplinary approaches from genomics to clinical radiology.

پروفایل رسمی دانشگاه

Crystal Chuمشاهده پروفایل

استادیار

University of VirginiaUnited States

Crystal Chu, PhD, is an Assistant Professor at the University of Virginia School of Nursing. She earned her doctorate in 2023 and transitioned from a post-doctoral fellowship to faculty position. Her research focuses on developing decision-making tools for breast cancer patients, particularly those considering contralateral prophylactic mastectomy (CPM) and advanced screening options. Her core research interests include: Patient decision aids for surgical oncology choices Risk communication in breast cancer screening Implementation of decision support tools in clinical practice Psychosocial aspects of cancer treatment decisions Dr. Chu's publications demonstrate consistent focus on oncology decision-making, with recent work expanding into pediatric oncology trials and environmental barriers to physical activity. Her research employs diverse methodologies including integrative reviews, pilot implementations, and randomized trials. She received the Young Scholar Award from the Medical Decision-Making Society for her innovative work on patient decision tools. Current research involves developing a comprehensive decision aid series addressing risk tolerance, economic factors, and decisional conflict across the breast cancer care continuum.

پروفایل رسمی دانشگاه

Karin Groothuis-Oudshoornمشاهده پروفایل

دانشیار

University of TwenteNetherlands

Karin Groothuis-Oudshoorn is an Associate Professor at the University of Twente, affiliated with the Health Technology & Services Research department and the TechMed Centre. She holds additional roles at the Digital Society Institute. Her expertise spans health economics, patient preference analysis, and AI applications in healthcare. She has received awards for teaching excellence, including the 2019 Best English Speaking Lecturer award and the 2017 Onderwijsprijs Health Science. Education: PhD in Artificial Intelligence from Utrecht University (1992–1996) Postdoc/Statistical Consultant at the University of Amsterdam (1996–1998) Biostatistician at TNO (1998–2002) and Roessingh Research and Development (2003–2010) Her research focuses on patient-centered methodologies, including discrete choice experiments, machine learning, and predictive modeling in oncology. She has published extensively on breast cancer recurrence prediction (e.g., the INFLUENCE model) and preference transferability in healthcare decision-making. Her work addresses SDGs related to health and well-being, leveraging AI for societal impact. Recent articles explore methodological advancements in preference elicitation and clinical prediction models. Awards: Decentral Education Prize (2019) Onderwijsprijs Health Science (2017) She has supervised master’s theses and contributed to external examinations in healthcare research. Her affiliations include multidisciplinary teams at TechMed Centre and the Digital Society Institute, emphasizing translational research between technology and healthcare systems.

پروفایل رسمی دانشگاه

Yoland Antillمشاهده پروفایل

دانشیار مدعو

Monash UniversityAustralia

Associate Professor Yoland Antill is an Adjunct Associate Professor at Monash University and a Medical Oncologist at Cabrini, Peninsula, and Melbourne Health Services in Australia. With over 20 years of experience in Medical Oncology and Cancer Genetics, her research focuses on breast and gynaecological cancers, hereditary cancer syndromes, and clinical trial development. She leads multiple international studies, including the OPTIMA and CAMBRIA-1 trials, and chairs ANZGOG's Uterine Tumour Working Group. Her advisory roles include Breast Cancer Network Australia and Ovarian Cancer Australia. She holds a BMed, FRACP, and MD. Education: Bachelor of Medicine (BMed), Fellowship of the Royal Australasian College of Physicians (FRACP), Medical Doctorate (MD) Key Roles: Medical Oncologist, Cancer Genetics specialist, Chair of ANZGOG Uterine Tumour Group, Industry advisory boards Research Interests Dr. Antill’s work emphasizes translational research in breast and gynaecological cancers, hereditary syndromes, and supportive care. Her studies explore novel therapies, genomic biomarkers, and improving patient outcomes through clinical trials. She has published extensively on topics like contralateral breast cancer risk, germline variants, and endometrial cancer staging. Projects & Trials Optimal Personalised Treatment of early breast cancer (OPTIMA) – Multi-parameter analysis for treatment optimization CAMBRIA-1 – Phase III trial of Camizestrant for ER+/HER2- early breast cancer VERITAC-3 – ARV-471 in advanced breast cancer Awards & Recognition No specific scientific awards listed, though her extensive clinical and research contributions are highlighted in peer-reviewed publications and industry collaborations.

پروفایل رسمی دانشگاه

Mohits Kakarsمشاهده پروفایل

استادیار

Riga Stradins UniversityLatvia

Mohits Kakars is an Assistant Professor in the Department of Paediatric Surgery at Rīga Stradiņš University. His academic qualification includes expertise in Clinical Medicine certified by the Latvian Council of Science (2024-2027). He actively contributes to UN Sustainable Development Goals, particularly in health-related targets. His research spans pediatric surgery, congenital disorders, and biomarkers, with specialized focus areas including: Appendicitis pathophysiology and SARS-CoV-2 impacts Genetic disorders like NTRK1 mutations and congenital pain insensitivity Surgical outcomes for esophageal atresia and inguinal hernia in premature infants Teratoma malignancy mechanisms Publications demonstrate consistent output since 2010, with recent work emphasizing international collaborations, pediatric surgical epidemiology, and COVID-19 complications. Notable trends include multicenter cohort studies and genetic case analyses. Awards & Recognition: Certificate of recognition (2025) He actively mentors through conference engagements and serves on scientific committees, including the European Pediatric Surgeons’ Association Congress (2024-2025).

پروفایل رسمی دانشگاه

John Boyagesمشاهده پروفایل

عضو هیئت علمی

Macquarie UniversityAustralia

John Boyages is an Honorary Professor of Breast Oncology at Macquarie University's Faculty of Medicine and Health Sciences and Director of the Australian Lymphoedema Education Research and Treatment (ALERT) centre. He specializes in breast cancer treatment, lymphedema management, and clinical leadership. His career spans over 35 years, including roles at Westmead Hospital and Harvard's Dana-Farber Cancer Institute. Affiliations: Macquarie University Hospital (Radiation Oncologist), ALERT Centre Director Education: University of Sydney (Medical Degree), Advanced training at Harvard Research focuses on breast cancer-related lymphedema, oncologic surgery, and radiation therapy. He leads 12 active/funded projects, including trials on lymphedema surveillance and bioimpedance spectroscopy. Over 213 publications highlight his work in oncology and lymphatic disorders. Notable awards include the Order of Australia (2017) and the Thomas Baker Travelling Fellowship (1987). He authored books like Male Breast Cancer and contributes to public health forums. Advising/Grants: Spearheaded the Westmead Breast Cancer Institute's one-stop diagnostic centre and multiple clinical trials. Collaborates internationally on lymphatic imaging and treatment protocols. Labs/Teams: Leads the ALERT Centre and collaborates with multidisciplinary teams in lymphedema research and surgical innovation.

پروفایل رسمی دانشگاه

Megan E Fracolمشاهده پروفایل

استادیار

Northwestern UniversityUnited States

Megan E Fracol is an Assistant Professor in Surgery (Plastic Surgery) at Northwestern University's Feinberg School of Medicine. She specializes in breast reconstruction and microsurgical techniques, with extensive training from MD Anderson Cancer Center and McGaw Medical Center of Northwestern University. Educational Background: Medical School: University of Pennsylvania Residency: McGaw Medical Center of Northwestern University Fellowship: MD Anderson Cancer Center in Microsurgical Reconstruction Clinical Expertise: Autologous breast reconstruction, implant-based breast reconstruction, breast implant-associated malignancies, microsurgical reconstruction, abdominal wall reconstruction, and extremity reconstruction after trauma or oncologic resection. Research Trends: Her work focuses on comparative outcomes in breast reconstruction techniques, immune responses to silicone implants, and microsurgical innovations for complex tissue defects across multiple anatomical regions.

پروفایل رسمی دانشگاه

Jochem van der Voort van Zypمشاهده پروفایل

دانشیار

Utrecht UniversityNetherlands

Jochem van der Voort van Zyp is an Associate Professor at Utrecht University , specializing in Radiation Oncology with a focus on Prostate Cancer and MRI-guided Radiotherapy . He is affiliated with the UMC Utrecht (University Medical Center Utrecht) and actively contributes to research in high-precision cancer therapies. Key Research Areas: Prostate Cancer, MR-guided Radiotherapy, Radiation Oncology, Medical Imaging Institution: Utrecht University / UMC Utrecht Contact: jvoortva@umcutrecht.nl His work explores advanced workflows for adaptive radiotherapy using integrated MRI-linear accelerator systems, aiming to reduce treatment toxicity while maintaining oncological outcomes. Recent publications (2025) analyze dose-volume parameters, geometric coverage, and acute toxicity in prostate cancer patients treated with 1.5 Tesla MR-linac technology.

پروفایل رسمی دانشگاه

Jacquelyn Bowerمشاهده پروفایل

استادیار

University of North Carolina at Chapel HillUnited States

Dr. Jacquelyn Bower is an Assistant Professor in the Department of Ophthalmology at the University of North Carolina at Chapel Hill's School of Medicine. She is a member of the UNC Lineberger Comprehensive Cancer Center with research focused on developing therapeutic strategies for uveal melanoma and DNA damage-related pathogenesis. Her lab investigates mutations in GNAQ/GNA11 proteins that drive tumor proliferation and metastasis, currently advancing preclinical studies for targeted therapies. Education: • PhD in Basic Pharmaceutical Sciences from West Virginia University (CDC/NIOSH) • Postdoctoral Fellowship at University of North Carolina at Chapel Hill Research Focus: Dr. Bower's work centers on ocular oncology and gene therapy, particularly exploiting molecular defects in uveal melanoma for therapeutic intervention. She develops AAV-based vectors for ocular diseases, including immunomodulatory approaches for autoimmune uveitis and corneal transplantation. Her secondary focus involves breast cancer mechanisms through Lineberger Cancer Center collaborations. Publication Trends: Recent articles (2021-2025) demonstrate concentrated work on AAV vector optimization for ocular applications, including toxicity reduction, biodistribution studies, and mutation-specific targeting of uveal melanoma. Over 80% of publications involve preclinical gene therapy models for anterior/posterior eye diseases. Awards and Honors: Career Development Award – American Society for Cell and Gene Therapy (2022) IBM Junior Faculty Development Award (2021) NIH Clinical Research Loan Repayment (2014-2016) Postdoctoral Research Excellence Award – UNC (2010) Sigma Xi Research Competition Winner (2005) Lab and Collaborations: Dr. Bower leads the Bower Lab at the Carolina Eye Research Institute, focusing on translational ocular oncology. She collaborates with UNC's Hematology/Oncology and Epidemiology departments on breast cancer recurrence mechanisms and maintains active NIH/NCI grant support.

پروفایل رسمی دانشگاه

Anne-Vibeke Lænkholmمشاهده پروفایل

دانشیار بالینی

University of CopenhagenDenmark

Anne-Vibeke Lænkholm serves as a Clinical Associate Professor within the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, based in pathology with clinical affiliations to Denmark's Capital Region (Region Hovedstaden) and Region Sjælland. Her research centers on advancing breast cancer diagnostics through molecular pathology and translational oncology. Her core research interests include molecular subtyping of breast cancer, BRCA genetic testing implementation, immune marker profiling (particularly in triple-negative subtypes), and pharmacological interventions like statins and targeted therapies. She investigates how genomic assays (e.g., Prosigna) and immune signatures influence treatment decisions, survival outcomes, and risk-reduction strategies in clinical practice. Analysis of her 2024-2025 publications reveals a dominant focus on population-based breast cancer research, integrating epidemiology, molecular diagnostics, and clinical outcomes. Key trends include optimizing BRCA testing timelines, validating genomic recurrence scores, exploring immune biomarkers for prognostication, and translating multiplex tissue profiling into clinical applications through international consortia. Scientific Awards: No awards are documented in the current profile. Advising and Grants: The available information does not specify student advising roles, grant funding, or laboratory leadership responsibilities.

پروفایل رسمی دانشگاه

Lars Ploug Boesenمشاهده پروفایل

دانشیار بالینی

University of CopenhagenDenmark

Lars Ploug Boesen serves as a Clinical Associate Professor within the Department of Clinical Medicine at the University of Copenhagen, specializing in urology and prostate cancer research under the Capital Region of Denmark (Region Hovedstaden) affiliation. His clinical work integrates advanced imaging techniques with practical urological interventions to improve patient outcomes. His research spans Urology, Prostate Cancer, Medical Imaging, MRI-guided Biopsy, Robotic Surgery, and Cancer Biomarkers, with emphasis on refining diagnostic protocols and reducing treatment complications. Key projects include optimizing MRI-guided prostate biopsies, evaluating continence recovery post-prostatectomy, and validating non-invasive biomarkers like the urine-based uCaP model. Analysis of his 2023-2025 publications reveals a cohesive focus on prostate cancer management, particularly MRI-driven biopsy innovations, antibiotic stewardship in office-based procedures, and risk stratification for PI-RADS 3 lesions. His work frequently involves multicenter collaborations through the Danish Prostate Cancer Consortium, addressing real-world clinical challenges in urological oncology. No scientific awards were documented in the provided materials. Details regarding student supervision or research grants were not specified in the available information. Dr. Boesen actively contributes to the Danish Prostate Cancer Consortium, shaping clinical guidelines for active surveillance and biopsy protocols. His research directly impacts evidence-based practices in prostate cancer diagnosis and treatment within Danish healthcare institutions.

پروفایل رسمی دانشگاه